Semaglutide targets one specific hormone pathway, while tirzepatide is a dual-action drug targeting both GLP-1 and GIP receptors
As treatment satisfaction is a leading indicator for treatment adherence, updated evidence for the DTSQ may be valuable in confirming the standard of HRQoL assessment among diabetes patients
This research is compelling and adds information to help counsel patients, since weve had limited data in this area, says Sonal Gandhi, MD, an obstetrician-gyncologist at Womens Health Arizona in Chandler, who wasnt involved in the new study
Real Results : A traveler with GLP-1s, syringes, and a USB cooler approaches TSA security at Denver International Airport
Losing weight too quickly without adequate protein intake and appropriate resistance exercise can lead to loss of lean muscle mass